Skip to main content
OpenTrials
Active, Not Recruiting

NCT Number: NCT05808699

Camera Qualification Study

A multi-center study to evaluate the performance of an automated device for the detection of diabetic retinopathy with the use of an additional fundus camera with IDx-DR.

Active, Not Recruiting

This study is active but is not currently recruiting participants.

Key information

Age range

22 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Infinity Clinical Research, Norco, California, United States

Loading trial locations.

About this study

A multi-center Study to demonstrate non-inferiority of the automated device detecting diabetic retinopathy using a handheld fundus camera with IDx-DR.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • 22 years of age or older
  • Documented diagnosis of diabetes mellitus, as per any of the following:
  • Having met the criteria established by either the World Health Organization (WHO) or the American Diabetes Association (ADA)
  • Hemoglobin A1c (HbA1c) ≥ 6.5%
  • Fasting Plasma Glucose (FPG) ≥ 126 mg/dL (7.0 mmol/L)
  • Oral Glucose Tolerance Test (OGTT) with two-hour plasma glucose (2-hr PG) ≥ 200 mg/dL (11.1 mmol/L), using the equivalent of an oral 75 g anhydrous glucose dose dissolved in water
  • Symptoms of hyperglycemia or hyperglycemic crisis with a random plasma glucose (RPG) ≥ 200 mg/dL (11.1 mmol/L)
  • Ability to understand and the willingness to sign a written informed consent document

Exclusion criteria

  • Currently participating in an interventional eye study
  • Has a known allergy to or contraindication for the use of Tropicamide 1% or other mydriatic eye drops
  • Has a condition that, in the opinion of a licensed clinical team member or investigator, would preclude participation in the study (e.g., unstable medical status including blood pressure or glycemic control, microphthalmia or previous enucleation)
  • Pregnancy
  • Self-report of visual symptoms including vision loss or blurred vision that cannot be corrected (e.g., with eyeglasses) or floaters
  • History of laser treatment of the retina, injections into either eye, or any history of retinal surgery
  • Previous confirmed diagnosis of a retinal disease (e.g., macular edema, severe non-proliferative retinopathy, proliferative retinopathy, radiation retinopathy, or retinal vein occlusion)
  • Any condition that is contraindicated for the use of the study camera
  • Contraindication for imaging by devices used in the study due to any of the following:
  • Subject is hypersensitive to light
  • Subject recently underwent photodynamic therapy (PDT)
  • Subject is taking medication that causes photosensitivity

Treatment and study plan

handheld fundus camera

Device

Fundus camera

Primary outcomes

  1. Sensitivity and Specificity Corrected for Enrichment

    Time frame: Day 1

    Estimation sensitivity and specificity corrected for enrichment using logistic regression, Level 1

Secondary outcomes

  1. Observed Sensitivity and Specificity, Level II

    Time frame: Day 1

    Estimation diagnosability, and observed sensitivity and specificity

Other outcomes

  1. Precision substudy

    Time frame: ~1-month after Day 1

    Evaluate the repeatability and reproducibility of IDx-DR with the camera in protocol DXSDR006.

    Additionally, another IRB-approved R&R study (i.e., similar to DXSDR006 precision substudy) was conducted to evaluate parameters that may optimize R&R outcomes.

Sponsors and collaborators

Lead sponsor

Digital Diagnostics, Inc.

Industry

Collaborators

  • Laboratory Corporation of America

Registry information

Official study title

Camera Qualification of an Additional Fundus Camera Paired With An Autonomous AI for Detecting Diabetic Retinopathy

Important dates

Study start
2023
Primary completion
2023
Study completion
2025
First posted
Apr 11, 2023
Registry last updated
Oct 22, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.